null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Mouse Anti-PD-1 (CD279) Fc Reduced (LALA-PG) Recombinant Monoclonal Antibody (IVMB0280)

SKU IVMB0280
Antibody Type Functional-Grade In Vivo Antibody
Disease Area Cancer Immunotherapy
Disease Area Autoimmune Diseases
Clone RMP1-14 (LALA-PG)
Protein PD-1
Isotype Mouse IgG2a k
Reactivity Mouse
Synonyms Programmed Death-1
Synonyms CD279
Synonyms PD1
Synonyms PDCD1
Research Area Apoptosis
Research Area Cancer
Research Area Cell Biology
Research Area Cell Death
Research Area Immunology
Research Area Inhibitory Molecules
Research Area Tumor Suppressors
Endotoxin Level Low Endotoxin
Host Species Mouse-Rat Chimeric
Applications Blocking
Applications FA
Applications In Vivo
Applications WB
€319 - €1,239
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

Anti-Mouse CD279 (PD-1) - Fc Reduced (LALA-PG) Recombinant Monoclonal Antibody

Introducing the Anti-Mouse CD279 (PD-1) Fc Reduced LALA-PG Recombinant Monoclonal Antibody from Assay Genie, an exceptional tool for researchers focusing on immune regulation and checkpoint pathways. This antibody targets Programmed Cell Death Protein 1 (PD-1), a critical checkpoint protein involved in the regulation of T-cell function and immune response. Engineered with a unique LALA-PG modification, this antibody ensures reduced Fc receptor binding, enhancing specificity and minimizing off-target effects. Ideal for applications in immunology research, PD-1 blockade studies, and cancer immunotherapy research, it offers unparalleled performance in various assays such as ELISA, flow cytometry, and functional assays. This product boasts high purity and low endotoxin levels, ensuring reliable and reproducible results.

It is available in a range of quantities to suit different experimental needs and is provided in a stable phosphate-buffered saline solution. Enhance your research capabilities with this versatile and high-quality antibody, designed to deliver precise and impactful results in studies related to immune checkpoints and therapeutic targets. PD-1, a crucial immune regulatory molecule, is predominantly expressed on T cells and plays a significant role in maintaining immune tolerance by inhibiting T-cell activation upon engagement with its ligands, PD-L1 or PD-L2. Understanding and targeting PD-1 pathways can lead to significant advancements in treatments for cancer, autoimmune diseases, and chronic infections.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose